e-learning
resources
Vienna 2012
Sunday, 02.09.2012
Pro-Con Debate "Severe community-acquired pneumonia: a lung disease?"
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Outcome of severe pneumonia: respiratory failure matters
R. Menendez Villanueva (Valencia, Spain)
Source:
Annual Congress 2012 - Pro-Con Debate "Severe community-acquired pneumonia: a lung disease?"
Session:
Pro-Con Debate "Severe community-acquired pneumonia: a lung disease?"
Session type:
Symposium
Number:
142
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Menendez Villanueva (Valencia, Spain). Outcome of severe pneumonia: respiratory failure matters. Annual Congress 2012 - Pro-Con Debate "Severe community-acquired pneumonia: a lung disease?"
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Lane-hamilton syndrome and CCF: a fatal association
Related content which might interest you:
Acute respiratory failure and severe sepsis may identify different clinical phenotypes in community-acquired pneumonia
Source: Annual Congress 2013 –Interesting research questions
Year: 2013
Characteristics of pnemococcal community-acquired pneumonia presenting with respiratory failure
Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment
Year: 2016
Differential characteristics of patients with mild acute respiratory distress syndrome due to community-acquired pneumonia admitted to ICU
Source: Annual Congress 2013 –Manifestations, scores and prognosis of community-acquired pneumonia
Year: 2013
Outcome of high-flow nasal cannula for acute hypoxemic respiratory failure due to pneumocystis pneumonia
Source: International Congress 2016 – New insights into noninvasive ventilation: between the dream and reality
Year: 2016
Risk factors for mortality in severe pneumonia patients followed in ICU
Source: International Congress 2015 – Acute critical care: novelties in critical care
Year: 2015
"Masks" of severe pneumonia (retrospective analysis of letal severe community-acquired pneumonia (sCAP))
Source: Annual Congress 2013 –Respiratory infections: a combination of problems needing early treatment
Year: 2013
NIV: indication in case of acute hypoxaemic respiratory failure (pulmonary oedema and immunosuppressed patients excluded)
Source: Eur Respir Mon; 2008: 41: 60–71
Year: 2008
Helmet ventilation in AIDS patients with severe pneumonia and acute hypoxaemic respiratory failure
Source: Annual Congress 2013 –NIV in the acute setting: growing experience and novel applications
Year: 2013
Severe community-acquired pneumonia: Characteristics and prognostic factors in ventilated and non-ventilated patients
Source: International Congress 2016 – Sepsis and ARDS: looking forward
Year: 2016
Predictors of outcome for patients with severe hypercapnic respiratory failure requiring NIV
Source: Annual Congress 2013 –New evidence for NIV in the acute setting
Year: 2013
Non-invasive ventilation (NIV) in community-acquired pneumonia CAP) and severe acute respiratory failure (ARF): Effectiveness and risk factors for failure and mortality
Source: Annual Congress 2011 - Recent advances in noninvasive ventilation used for treating acute respiratory failure
Year: 2011
Severe respiratory infection: when is ICU mandatory?
Source: Annual Congress 2012 - Respiratory infectious diseases Grand Round: an interactive session
Year: 2012
Arterial oxygen content could reflect acute organ damage in community-acquired pneumonia
Source: International Congress 2014 – Respiratory infections: inflammation and treatment
Year: 2014
Smoking status and respiratory infections during mechanical ventilation
Source: Annual Congress 2013 –Respiratory infections: a combination of problems needing early treatment
Year: 2013
Effects of using the 2007 IDSA/ATS minor criteria to manage severe community-acquired pneumonia
Source: Annual Congress 2013 –Recent developments in pneumonia
Year: 2013
Non-invasive ventilation in acute respiratory failure: Non-formal indications
Source: Annual Congress 2013 –NIV in the acute setting: growing experience and novel applications
Year: 2013
Respiratory pathogens, immunodeficiency or systemic response – What comes first in the etiology of severe community-acquired pneumonia (sCAP)
Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections
Year: 2013
Factors contributing to severe pneumonia in patients with chronic obstructive pulmonary disease
Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections
Year: 2014
Non invasive ventilation in acute respiratory failure due to COPD vs non COPD conditions: Effectiveness and failure predictors
Source: International Congress 2015 – Outcome of noninvasive ventilatory support in acute and chronic respiratory failure
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept